Skip to main content

Advertisement

SpringerLink
Log in

Imatinib Mesylate (Gleevec) Hepatotoxicity

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Abbreviations

CML::

Chronic myeloid leukemia

GIST::

Gastrointestinal stromal tumor

IM::

Imatinib mesylate

References

  1. Johnson JR, Bross P, Cohen M, Rothmann, Chen G, Zajicek A, Gobburu J, Rahman A, Staten A, Pazdur R (2003) Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase. Clin Cancer Res 9:1972–1979

    PubMed  CAS  Google Scholar 

  2. Guilhot F (2004) Indications for imatinib mesylate therapy and clinical management. The Oncologist 9:271–281

    Article  PubMed  CAS  Google Scholar 

  3. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantajian H, Capdeville R, Ohno-Jones S, Sawyers CL (2001) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031–1037

    Article  PubMed  CAS  Google Scholar 

  4. Kikuchi S, Muroi K, Takahashi S, Kawano-Yamamoto C, Takatoku M, Miyazato A, Nagai T, Mori M, Komatsu N, Ozawa K (2004) Severe hepatitis and complete molecular response caused by imatinib mesylate: possible association of its concentration with clinical outcomes. Leukemia Lymphoma 45:2349–2351

    Article  PubMed  Google Scholar 

  5. Novartis (2006) Gleevec® (Imatinib mesylate).www.gleevec. com. Cited 2006

  6. Ohyashiki K, Kuriyama Y, Nakajima A, Tauchi T, Ito Y, Miyazawa K, Kimura Y, Serizawa H, Ebihara Y (2004) Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis. Leukemia 16:2160–2161

    Article  Google Scholar 

  7. Cohen MH, Williams G, Johnson JR, Duan J, Gobburu J, Rahman A, Benson K, Leighton J, Kim SK, Wood R, Rothmann M, Chen GUKM, Staten AM, Pazdur R (2002) Approval Summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin Cancer Res 8:935–942

    PubMed  CAS  Google Scholar 

  8. Lin NU, Sarantopoulos S, Stone JR, Galinsky I, Stone RM, Deangelo DJ, Soiffer RJ (2003) Fatal hepatic necrosis following imatinib mesylate therapy. Blood 102:3455–3456

    Article  PubMed  CAS  Google Scholar 

  9. James C, Trouette H, Marit G, Cony-Makhoul P, Mahon F-X (2003) Histological features of acute hepatitis after imatinib mesylate treatment. Leukemia 17:978–979

    Article  PubMed  CAS  Google Scholar 

  10. Ayoub WS, Geller SA, Tran T, Martin P, Vierling JM, Poordad FF (2005) Imatinib (Gleevec®)-induced hepatotoxicity. J Cin Gastroenterol 39:75–77

    CAS  Google Scholar 

  11. Consult MD (2005) Celecoxib. www. mdconsult.com. Cited 2005

Download references

Acknowledgments

Dr. Ayse Leyla Mindikoglu was supported by the 2004 American Association for the Study of Liver Diseases (AASLD) Advanced Hepatology Fellowship Award.

Author information

Authors and Affiliations

  1. Center for Liver Diseases, Division of Hepatology, University of Miami Leonard M. Miller School of Medicine, 1500 N.W. 12th Avenue, Suite 1101, Miami, FL, 33136, USA

    Ayse L. Mindikoglu, Arie Regev, Enrique J. Martinez, Lennox J. Jeffers & Eugene R. Schiff

  2. Department of Pathology, University of Miami Leonard M. Miller School of Medicine, Miami, Florida, USA

    Pablo A. Bejarano

Authors
  1. Ayse L. Mindikoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arie Regev
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pablo A. Bejarano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Enrique J. Martinez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lennox J. Jeffers
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eugene R. Schiff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arie Regev.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mindikoglu, A.L., Regev, A., Bejarano, P.A. et al. Imatinib Mesylate (Gleevec) Hepatotoxicity. Dig Dis Sci 52, 598–601 (2007). https://doi.org/10.1007/s10620-006-9117-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9117-1

Keywords

Search

Navigation